Despite the overall bearish trend in April, the pharmaceutical sector stands out, with stocks like Astral, Aurobindo Pharma, Sun Pharma, Glenmark, NALCO, and Oil India performing well. Conversely, ICICI Prudential Life and BEL exhibit negative trends, suggesting potential challenges ahead. Investors should keep a close eye on the critical support at 21,700 for the Nifty index.

Ambit Capital recommends a buy position for Astral, with its current price standing at ₹1571 as of April 1st. This suggests potential growth opportunities for investors interested in the stock market.